TAKEDA PHARMACEUTICALS

Zydus Cadila gets US-FDA nod for antidepressant drug

2021-09-182021-09-18 | Trisha Thomas

Zydus Cadila said it received approval from the US Food & Drug Administration to sell new generation anti-depressant Vortioxetine in the US market. The drug was first approved around seven years ago, and was developed by Denmark-based pharmaceuticals maker Lundbeck in the late 2000s. Around 2007, Japanese pharmaceuticals maker Takeda agreed to pay an upfront […]

Zydus Cadila ties up with Takeda Pharmaceuticals for chikungunya vaccine

2016-09-20 | Devika Nithin

Zydus Cadila, a global healthcare provider, and Takeda Pharmaceutical Company Limited, one of the world´s largest pharmaceutical companies, announced a partnership to develop vaccine for chikungunya, an emerging infectious disease. The broadbased agreement includes early stage development to the final commercialisation of the vaccine against chickungunya. There is currently no vaccine to prevent or medicine to treat […]